| 标题 |
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Selim Corbacioglu; Holger Lode; Susanne Ellinger; Florian Zeman; Meinolf Suttorp; et al 出版日期:2024-07-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)